Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
McKesson
Federal Trade Commission
Colorcon
Cerilliant
Queensland Health
Chubb
Harvard Business School
Fish and Richardson

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076134

« Back to Dashboard

NDA 076134 describes LORATADINE, which is a drug marketed by Marksans Pharma, Taro, Apotex Inc, Lannett Co Inc, Perrigo, Ranbaxy Labs Ltd, Taro Pharm, Teva, Wockhardt Bio Ag, Sun Pharma Global, Actavis Labs Fl Inc, Aurobindo Pharma Ltd, Perrigo Pharma Intl, Pfizer, Mylan, Pld Acquisitions Llc, and Sun Pharm Inds Ltd, and is included in thirty NDAs. It is available from one hundred and thirty-five suppliers. Additional details are available on the LORATADINE profile page.

The generic ingredient in LORATADINE is loratadine; pseudoephedrine sulfate. There are thirty-nine drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the loratadine; pseudoephedrine sulfate profile page.
Summary for 076134
Tradename:LORATADINE
Applicant:Sun Pharm Inds Ltd
Ingredient:loratadine
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 076134
Suppliers and Packaging for NDA: 076134
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LORATADINE loratadine TABLET;ORAL 076134 ANDA Kaiser Foundation Hospitals 0179-8317 N 0179-8317-01
LORATADINE loratadine TABLET;ORAL 076134 ANDA Kaiser Foundation Hospitals 0179-8317 N 0179-8317-30

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength10MG
Approval Date:Aug 18, 2003TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Chubb
QuintilesIMS
AstraZeneca
Deloitte
Boehringer Ingelheim
Merck
Julphar
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.